FDA
approval
· 2022-03-23
FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) from ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)